RETROVIR SYRUP

ViiV Healthcare Limited

Revision date : 2021-06-18

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 4
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

200-289-5/56-81-5

Name of the chemical

glycerol

Concentration

N/A

EC/CAS

201-069-1/77-92-9

Name of the chemical

Citric acid

Concentration

N/A

EC/CAS

208-534-8/532-32-1

Name of the chemical

Benzoic acid and its sodium salt

Concentration

N/A

General Information

Revision date

2021-06-18

Product name

RETROVIR SYRUP

Product Synonyms

RETROVIR SYRUP 50 MG/5 ML * RETROVIR/AZT ORAL SOLUTION 10 MG/ML * RETROVIR

Emergency telephone

VERISK 3E GLOBAL INCIDENT RESPONSE

Icons in SDS

GHS08

Company Information

company name

ViiV Healthcare Limited

e-mail address of the competent person responsible for the Safety Data Sheet

msds@gsk.com

GHS Information

Signal word

Warning

Hazard Codes

Hazard statements (CLP)

H341, H351

Hazard statements

Code

Statements

H341

Suspected of causing genetic defects

Section 2

2.1 Classification of the substance or mixture

The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.

EU Classification

Regulation (EC) No 1272/2008 as amended

Health hazards

Germ cell mutagenicity Category 2 H341 - Suspected of causing genetic defects. Carcinogenicity Category 2 H351 - Suspected of causing cancer. Hazard summary Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.

2.2 Label elements

Label according to Regulation (EC) No. 1272/2008 as amended

Contains

CITRIC ACID ANHYDROUS, GLYCERIN, SODIUM BENZOATE, ZIDOVUDINE

Signal word

Warning

Hazard statements

H341 Suspected of causing genetic defects. H351 Suspected of causing cancer.

Prevention

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection.

Response

P308 + P313 IF exposed or concerned: Get medical advice/attention.

Storage

P405 Store locked up.

Disposal

P501 Dispose of contents/container in accordance with local/regional/national/international regulations.

Supplemental label elements

1 % of the mixture consists of component(s) of unknown acute dermal toxicity. 64 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 11 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 11 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. EUH208 - Contains ART STRAWBERRY FLAVOUR - PHL-134189. May produce an allergic reaction.

2.3 Other hazards

Caution - Pharmaceutical agent. This mixture does not contain substances assessed to be vPvB / PBT according to Regulation (EC) No 1907/2006, Annex XIII. The product does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. See section 11 of the SDS for additional information on health hazards.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.